by Chirac P and Torreele E. The Lancet, May 2006, 367:1560-1.
Summary: One of the critical issues to be discussed at the next World Health Assembly (Geneva , May 22-26) will be a resolution about a global framework on essential health research and development. Over the past years, the crisis in research and development in the worldwide pharmaceutical industry, and in particular the absence of research and development for new medicines targeting diseases that mainly affect people in developing countries (neglected diseases), has become a global concern.
